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Abstract
Introduction: Several studies have demonstrated that perioperative hemodynamic optimization has the ability to
improve postoperative outcome in high-risk surgical patients. All of these studies aimed at optimizing cardiac
output and/or oxygen delivery in the perioperative period. We conducted a survey with the American Society of
Anesthesiologists (ASA) and the European Society of Anaesthesiology (ESA) to assess current hemodynamic
management practices in patients undergoing high-risk surgery in Europe and in the United States.
Methods: A survey including 33 specific questions was emailed to 2,500 randomly selected active members of the
ASA and to active ESA members.
Results: Overall, 368 questionnaires were completed, 57.1% from ASA and 42.9% from ESA members. Cardiac
output is monitored by only 34% of ASA and ESA respondents (P = 0.49) while central venous pressure is
monitored by 73% of ASA respondents and 84% of ESA respondents (P < 0.01). Specifically, the pulmonary artery
catheter is being used much more frequently in the US than in Europe in the setup of high-risk surgery (85.1% vs.
55.3% respectively, P < 0.001). Clinical experience, blood pressure, central venous pressure, and urine output are the
most widely indicators of volume expansion. Finally, 86.5% of ASA respondents and 98.1% of ESA respondents
believe that their current hemodynamic management could be improved.
Conclusions: In conclusion, these results point to a considerable gap between the accumulating evidence about
the benefits of perioperative hemodynamic optimization and the available technologies that may facilitate its
clinical implementation, and clinical practices in both Europe and the United States.
Introduction
Mortality and morbidity related to anesthesiology have
significantly decreased during the last decade, mainly
due to improvements in patients’ safety in general, as
well as better risk stratification and better management.
However, complications following major surgery are still
a leading cause of perioperative morbidity and mortality
[1,2]. High-risk surgical patients represent only about
10% of the overall anesthesiology procedures performed
each year, and yet these patients account for over 80%
of perioperative deaths [3]. This represents a substantial
global public-health concern since it is estimated that
234 million major surgical procedures are performed
worldwide each year including 40 millions in the US
alone [4].
Several studies have demonstrated that perioperative
hemodynamic optimization has the ability to improve
postoperative outcome in high-risk surgical patients
[5-7]. Specifically, hemodynamic optimization in patients
undergoing high-risk surgery has been shown to
decrease the incidence of postoperative complications,
to decrease length of stay in the intensive care unit and
in the hospital, to decrease the overall cost of surgery
[6], and to possibly improve long-term survival [8].
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may be considered unethical not to use goal-directed
perioperative therapy once patient identification and the
methods to be used in treating them are refined [9].
And yet, the principles of perioperative optimization are
not applied uniformly, if at all, and there is a great
variability in their adoption into clinical practice.
Part of the observed non-uniformity in the clinical
application of perioperative optimization may be due to
the prevalent different practices in hemodynamic moni-
toring with regard mainly to the measurement of cardiac
output (CO). The most frequent parameters that have
been used for perioperative optimization are cardiac
o u t p u t( C O )a n d / o ro x y g e nd e l i v e r y( D O 2 ) .A l t h o u g h
the proclaimed gold standard for cardiac output mea-
surement is still intermittent thermodilution by the pul-
monary artery catheter (PAC), the use of this device has
dramatically decreased in surgical patients over the past
15 years [10]. This decrease is mostly related to the fact
that the PAC is highly invasive and has several asso-
ciated risks [10]. One should consider, however, that the
apparent decline in the use of PACs is due to both a
shift in philosophy and its replacement by new technol-
ogies [11].
The aim of the present study is, therefore, to assess and
report current hemodynamic management practices in
patients undergoing high-risk surgery in Europe and in
the United States using a self reported internet survey.
The results from this study will help to determine the
potential need for future educational endeavors and prac-
tice guidelines regarding hemodynamic monitoring and
management in patients undergoing high-risk surgery.
Materials and methods
A survey of 33 questions was developed to assess the
current trend in hemodynamic management and moni-
toring for high-risk surgery patients. Twelve questions
were related to the respondents’ d e m o g r a p h i cd a t aa n d
practice.
The Institutional Review Board at the University of
California Irvine approved the study. An invitation to
participate in the survey was emailed through the Amer-
ican Society of Anesthesiology (ASA) e-newsletter to
2,500 randomly selected active members of the ASA,
representing approximately 10% of the active member-
ship. At the same time, an email was sent through the
European Society of Anaesthesiology (ESA) office to
active ESA members with a link to the survey and a link
to the survey was posted on the European Society of
Anaesthesiology website. Below is the invitation that
was sent to ASA and ESA members:
Dear ASA/ESA member,
We are inviting you to participate in
a research project regarding our cur-
rent practices of hemodynamic moni-
toring and management in patients
undergoing high-risk surgery. Infor-
mation regarding your practice,
experiences, philosophies, and
training will be used to assess the
potential need for future educational
endeavors and practice guidelines.
The way in which patients are moni-
tored and their outcomes are opti-
mized is rapidly evolving and
improving. However, setting a stan-
dard of care with the use of new meth-
ods has yet to be achieved. In
particular, hemodynamic monitors and
indices available in high-risk sur-
gery patients have markedly evolved.
Currently, even if pulmonary artery
catheterization remains the gold
standard for hemodynamic monitoring
in high-risk patients, its use has
dramatically declined (63%) in the
last 15 years. While this decline is
largely due to the fact that the
device is highly invasive and has
several associated risks, it may also
be due to changes in philosophy or
implementation of new technologies.
This questionnaire has been approved
by the ASA/ESA for distribution to
its members. At the end of this email
there is a link to a 33-question Sur-
vey Monkey questionnaire, which
should take about 10 minutes to com-
plete. Participation in this ques-
tionnaire is completely voluntary
and anonymous. We hope that you will
take the time to fill out this ques-
tionnaire and help us to uncover the
potential need for standardizing
hemodynamic practices in high-risk
surgical patients.
Resident, affiliate, honorary, life, and retired members
were excluded. A covering letter explained that the data
collected would be anonymous and be non-attributable.
Participants accessed a Web site linked to a secure data-
base (Survey Monkey, Palo Alto, CA, USA). The survey
was opened from 1 October 2010 to 31 December 2011.
To maximize response rate, we sent two sequential e-
mails to the participants during the study period.
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In the survey, high risk surgery patients were defined
and presented according to the definition presented
below:
For the following questionnaire, we will define
high risk surgery patients as patients aged 18
years or older presenting for major surgery
expected to last more than 1.5 hours and having
at least two of the following criteria:
1. Cardiac or respiratory illness resulting in func-
tional limitation
2. Extensive surgery planned for carcinoma
involving bowel anastomosis
3. Predictable acute massive blood loss (> 2.5
liters)
4. Aged over 70 years with functional limitation
of one or more organ systems
5. Septicemia (positive blood cultures or septic
focus)
6. Respiratory failure (PaO2 < 8 kPa on FiO2 >
0.4, that is, PaO2:FiO2 ratio < 20 kPa or ventila-
tion > 48 hours)
7. Acute abdominal catastrophe (for example,
pancreatitis, perforated viscous, gastro-intestinal
bleed)
8. Acute renal failure (urea > 20 mmol l
-1, creati-
nine > 260 μmol l
-1)
9. Surgery for abdominal aortic aneurysm
10. Disseminated malignancy
This definition has been used in previously published
studies on the topic both in the US and in Europe
[5,12,13]. The full questionnaires sent to ASA and ESA
members are presented in Appendix 1 and 2
respectively.
Statistical analysis
Categorical data are expressed as frequency. Data were
analyzed according to the number of responses we
obtain for each given question. Categorical items were
analyzed by frequency distribution and c2a n a l y s i s .I n
all cases, two-tailed P-values of 0.05 or less were consid-
ered evidence of differences not attributable to chance.
All analyses were performed using SPSS 11.0 (SPSS Inc.,
Chicago, IL, USA).
Results
Respondents’ description
We received 217 responses from ESA members and 273
responses from ASA members. Total completed ques-
tionnaires were 158 (72.8%) for ESA members and 210
(76.9%) for ASA members. Overall, 368 questionnaires
were completed, including 57.1% from ASA members
and 42.9% from ASA members.
ASA respondents’ descriptions
ASA respondents are working mostly (48%) in private
practice with lesser numbers working in general hospi-
tals (24.2%) and in university hospitals (25.4%). About
half (51.8%) of them take care of high risk surgery
patients 1 to 5 times a week and about a third (35.1%)
of them do it 6 to 10 times a week, with only 13.8% of
them taking care of cardiac surgery patients. Half of
them had further training, including a fellowship in car-
diac anesthesia (48.5%) and in critical care (25.8%).
About a third (33.8%) finished their training after 2000
and 6.2% before 1980. Only 31.6% of the ASA respon-
dents manage high-risk surgical patients in the intensive
care unit.
ESA respondents description
ESA respondents are working mostly (54.0%) in univer-
sity hospitals, with lesser numbers working in general
hospitals (37.6%) and in private practice (5.0%). The
majority, (72.8%), take care of high-risk surgery patients
1 to 5 times a week and 18.3% do it 6 to 10 times a
week, with 10.3% taking care of cardiac surgery patients.
One third (31.2%) of ESA member respondents had
further training, including a fellowship in critical care
(58.3%) or in cardiac anesthesia (33.3%). About half
(45.8%) finished their training after 2000 and 7.1%
before 1980. The majority (79.7%) of ESA respondents
manage high-risk surgical patients in the intensive care
unit.
Although more ASA respondents work in private
practice than ESA respondents (48.0% vs. 5.0%; P <
0.001), they manage high-risk surgery patients more
o f t e nt h a nE S Ar e s p o n d e n t s( 6t o1 0t i m e s / w e e ki n
35.1% of ASA respondents vs. 18.7% of ESA respon-
dents; P < 0.001). Interestingly, 18.6% of ESA respon-
dents work in hospitals of > 1,000 beds (vs. 5.7% ASA
respondents; P < 0.001); yet intensive care units with >
40 beds are more frequent in the US (37.9% ASA vs.
17.8% ESA; P < 0.001). For ESA respondents, critical
care and anesthesiology belong to the same group; this
is different for ASA respondents (Figure 1). ESA respon-
dents seem to be younger: 46.2% of them finished train-
ing after 2000 (vs. 33.8% of ASA respondents; P <
0.001). The term “fellowship” seems unfamiliar to ESA
respondents: 24.1% of them answer “not applicable” (vs.
0% of ASA respondents).
Hemodynamic monitoring and management practices
Hemodynamic monitoring practices seem to differ con-
siderably between Europe and the USA (Table 1), with
more Europeans having written protocols concerning
hemodynamic management in high-risk surgical patients
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0.001) (Figure 2).
Invasive blood pressure and central venous pressure
monitoring
While invasive arterial pressure is monitored and used
for hemodynamic optimization by more than 90% of
both ASA and ESA respondents, there seems to exist
significant heterogeneity in the way CVP and CO are
being monitored and used (Figure 3). Interestingly, CVP
is monitored by 84% of ESA respondents and by 73% of
ASA respondents (P <0 . 0 5 ) .I nc o n t r a s t ,E S Ao rA S A
respondents rarely optimize CVP while most of them
optimize arterial pressure.
Cardiac output monitoring
Although CO is being monitored by only about 34% of
both ASA and ESA respondents (P = 0.491), we
observed significant differences regarding the techniques
used for CO monitoring by ASA and ESA respondents
(Figure 4). Specifically, the PAC is being used much
more frequently in the US th a ni nE u r o p ei nt h es e t u p
of high-risk surgery (85.1% vs. 55.3% respectively, P <
0.001). On the other hand, the PiCCO monitor is used
in this setup by 44.0% of ESA respondents and by only
1.1% of ASA respondents (P < 0.001). When respon-
dents reported that they do not monitor CO, the main
reason given by both groups was that they monitor
dynamic parameters of fluid responsiveness as surro-
gates for CO monitoring (Table 2). Additionally, tech-
nologies for CO monitoring are considered by the non-
users of both groups to be too invasive (Table 2). Inter-
estingly, although CO is being measured by only a third
of ASA and ESA respondents, nearly all respondents
agree that oxygen delivery is of major importance for
patients undergoing high-risk surgery, with more than
90% exhibiting the knowledge that CO is a major deter-
minant of oxygen delivery.
Dynamic parameters of fluid responsiveness
Parameters considered by both ASA and ESA respon-
d e n t sa si n d i c a t o r sf o rv o l u m ee x p a n s i o na r es h o w ni n
Table 3. Clinical experience, blood pressure, CVP, and
urine output are the most widely seen indicators of
volume expansion. ESA respondents are more likely to
Figure 1 Do you or your department/group manage these patients in the intensive care unit?
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on arterial pressure analysis than ASA respondents. The
way ASA and ESA respondents assess the hemodynamic
effects of a volume expansion is shown in Table 4. Para-
meters considered as the best predictors of fluid respon-
siveness by ASA and ESA respondents are shown in
Table 5.
Respiratory variations in the plethysmographic wave-
form are being used by 25% of ASA and ESA respon-
dents. Respiratory variations in arterial pressure are
eyeballed by 90.3% of ASA respondents compared with
68.0% of ESA respondents (P < 0.001), manually calcu-
lated by 9.7% of ASA respondents and by 20.6% of ESA
respondents, and monitored using specific software by
5.1% of ASA respondents versus 22.9% of ESA respon-
dents (P < 0.001). These parameters are optimized more
than 50% of the time by 31.2% of ASA respondents and
by 28.4% of ESA respondents (P < 0.298).
A significant difference was observed regarding the
type of fluid used by ASA and ESA respondents. Crys-
talloid is the first line therapy used by ASA respondents
while ESA respondents chose starches (Figure 5).
To the question: “Do you believe that your current
hemodynamic management could be improved?” 86.5%
of ASA respondents and 98.1% of ESA respondents (P <
0.001) answered “Yes”.
Discussion
The main finding of this international survey is that
despite evidence showing that CO optimization during
high risk surgery has the potential to improve post-
operative patient outcome, and despite the fact that
nearly all respondents agreed that oxygen delivery is of
major importance for patients undergoing high-risk sur-
gery, only 34% of anesthesiologists in Europe and in the
US monitor CO in this setting. More importantly, even
those who monitor CO rarely use its value for perio-
perative optimization as recommended in recent articles
[6,8]. Interestingly, 86.5% of ASA respondents and
98.1% of ASA respondents believe that their current
hemodynamic management could be improved. The
other findings of this survey point out significant differ-
ences in the choice and interpretation of monitoring
techniques between American and European
anesthesiologists
The role of CO monitoring and optimization in
improving outcome in high-risk surgery is being repeat-
edly demonstrated in recent years [6,7,14]. Yet, as our
study clearly demonstrates, the adoption of this thera-
peutic approach is far from being universal. This is
reflected by the fact that most of the responding centers
do not have clear recommendations or guidelines for
hemodynamic management of high-risk surgery patients
(Figure 1). One of the main reasons for the apparent
reluctance to monitor CO is the belief that in and by
itself CO is not an important parameter, and that the
clinicians may be better off by using other parameters,
like dynamic predictors of fluid responsiveness, as surro-
gates of CO (Table 2) [15]. However, only 24.2% of ASA
respondents and 14.1% of ESA respondents think that
CO monitoring does not provide any additional clini-
cally relevant information for the management of high-
risk surgery patients. A much larger portion of the
respondents, 48.4% of the ASA and 26.8% of the ESA,
do not monitor CO because they feel that available solu-
tions are too invasive. Another explanation for the rela-
tive scarcity of CO monitoring, which was not explored
in our study, is the uncertainty of anesthesiologists
about the value of perioperative optimization in general,
in view of the studies that have shown that fluid restric-
tion might be beneficial for high-risk surgical patients
[16,17].
More than 50% of respondents stated that they are
using dynamic predictors of f l u i dr e s p o n s i v e n e s sa sa
surrogate for CO monitoring. The ability of dynamic
parameters to predict fluid responsiveness accurately
has been extensively demonstrated [18-21]. Indeed,
functional hemodynamic parameters may be helpful in
identifying fluid responders prior to hemodynamic opti-
mization, and, more importantly, identify those patients
Table 1 Hemodynamic monitoring used for the
management of high-risk surgery patients?.
ASA
respondents
(n = 237)
ESA
respondents
(n = 195)
Answer options Response
percent
Response
percent
Invasive arterial pressure 95.4% 89.7%
Central venous pressure 72.6% 83.6%
Non-invasive arterial pressure 51.9% 53.8%
Cardiac output 35.4% 34.9%
Pulmonary capillary wedge
pressure
30.8% 14.4%
Transesophageal
echocardiography
28.3% 19.0%
Systolic pressure variation 20.3% 23.6%
Plethysmographic waveform
variation
17.3% 17.9%
Pulse pressure variation 15.2% 25.6%
Mixed venous saturation (ScvO2) 14.3% 15.9%
Central venous saturation (SvO2) 12.7% 33.3%
Oxygen delivery (DO2) 6.3% 14.4%
Stroke volume variation 6.3% 21.5%
Near infrared spectroscopy 4.6% 5.1%
Global end diastolic volume 2.1% 8.2%
ASA, American society of anesthesiology respondents; ESA, European society
of anaesthesiology respondents.
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vent detrimental fluid overload. However, studies show-
ing an impact of hemodynamic management based on
these parameters on patients’ outcome are still lacking
and so far we have no strong evidence supporting this
hypothesis [22]. Moreover, it has been shown recently
that about 60% of patients present at least one limitation
to the use of dynamic parameters in the operating room
[23]. Finally, about 90% of ASA respondents and 70% of
ESA respondents only eyeball these variations preclud-
ing any strong clinical application.
Our results show that there are significant differences
between American and European anesthesiologists in
the practice of hemodynamic monitoring. It seems that
most clinicians in the US still associate CO monitoring
with the use of the Swan-Ganz catheter (Figure 4) while
other less invasive monitors are not widely known or
used. For example, the transpulmonary thermodilution
method that is applied in the PiCCO
® a n di su s e db y
44.0% of the ESA respondents, seems to be virtually
unknown to most clinicians in the US. This could be
explained by the fact that this technology requires a
femoral arterial line, which is not the standard of care
in the US [24]. Another explanation is that technologies
seem to spread most in the countries and regions where
they are developed and manufactured, due most prob-
ably to the involvement of local opinion leaders in the
development and validation phases, as well as in the
marketing efforts, but this has to be demonstrated. The
observed differences between European and US prac-
tices in terms of technology and hemodynamic know-
how may also stem from the fact that anesthesiologists
in Europe are more likely to be ICU and because they
manage patients in the ICU more frequently than their
American colleagues (Figure 2). We postulate that this
may also explain our finding that the number of ESA
respondents who use the mixed venous oxygen satura-
tion (SvO2) and/or central venous oxygen saturation
(ScVO2) as surrogates for CO monitoring is double
than that of ASA respondents since goal directed ther-
apy based on ScvO2 optimization has been validated in
septic patients in the intensive care unit [25].
An intriguing finding of our study relates to the moni-
toring of central venous pressure (CVP) which is still
Figure 2 Incidence of institutional guidelines concerning hemodynamic management in this setting?
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despite consistent evidence that filling pressures are
unreliable in predicting fluid responsiveness [26,27] and
that they have numerous limitations [28]. Since most
clinicians who monitor CVP admit that they do not try
to optimize it (Figure 3), it is unclear how CVP is inte-
grated into the physicians’ clinical decision-making pro-
cess. In 2007, in an editorial published in Critical Care
Figure 3 How frequently do you try to optimize central venous pressure, arterial pressure, and cardiac output in this setting?
Cannesson et al. Critical Care 2011, 15:R197
http://ccforum.com/content/15/4/R197
Page 7 of 11Medicine, Dr. Parker claimed that better methods for
determining cardiac preload and cardiac performance
are badly needed to guide the clinician in the manage-
ment of our critically ill patients, but until these meth-
o d sb e c o m em o r ew i d e l ya v a i l a b l ew ea r el e f tw i t h
pressure measurements and clinical judgment [29]. This
seems to still be the case for many anesthesiologists,
even though new technologies and devices, including
those that monitor dynamic predictors of fluid respon-
siveness, are indeed widely available.
Study limitations
The accuracy of our survey can be impacted by ascer-
tainment and non response bias. Our response rate was
relatively small, and the clinicians who responded may
not be representative, which could impact the external
Figure 4 What technique do you use to monitor cardiac output? (Please, mark all that apply).
Table 2 Main reasons for not monitoring cardiac output?
ASA Respondents
(n = 157)
ESA Respondents
(n = 142)
Answer Options Response Percent Response Percent
I use dynamic parameters of fluid responsiveness (Pulse Pressure Variations, Systolic Pressure Variations,
Plethysmographic Waveform Variations) as surrogates for cardiac output monitoring
54.1% 60.6%
Available cardiac output monitoring solutions are too invasive 48.4% 26.8%
Cardiac output monitoring does not provide any additional clinically relevant information in this setting 24.2% 14.1%
I use SvO2 and/or ScVO2 as surrogates for cardiac output monitoring 13.4% 26.1%
Available cardiac output monitoring solutions are unreliable 8.3% 15.5%
ASA, American society of anesthesiology respondents; ESA, European society of anaesthesiology respondents.
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online or email surveys, and has been well documented
[30,31]. One way of bypassing this limitation is to use a
professional mailing list in order to reach a specific tar-
get population [31] as we did in the present study. How-
ever, it is interesting to observe the concordance
between ESA and ASA respondents’ answers and our
results seem in accordance with commonly observed
practice in Europe and in the US. Moreover, our goal
was not to develop recommendations based on the
extent of existing practice, but rather to establish a base-
line against which consensus proposals would be devel-
oped. We also believe these results can be used in the
future to assess the effects of guidelines/recommenda-
tions on clinical practice and hemodynamic monitoring/
management in patients undergoing high risk surgery.
Conclusions
In conclusion, these results point to a considerable gap
between the accumulating evidence about the benefits
of perioperative hemodynamic optimization and the
available technologies that may facilitate its clinical
Table 3 What are your indicators for volume expansion
in this setting (diagnostic tools)?
ASA
Respondents
(n = 209)
ESA
Respondents
(n = 165)
Answer Options Response
Percent
Response
Percent
Blood pressure 88.5% 77.6%
Urine output 83.3% 77.0%
Clinical experience 77.5% 64.8%
Central venous pressure 70.8% 64.2%
Cardiac output 49.3% 53.3%
Pulse Pressure Variation or Systolic
Pressure Variation
45.0% 55.8%
Transesophageal echocardiography 43.5% 28.5%
Pulmonary capillary wedge pressure 38.8% 24.2%
Plethysmographic Waveform Variation 25.4% 25.5%
Stroke Volume Variation 19.1% 36.4%
Mixed venous saturation (ScvO2) 18.7% 21.8%
Global end diastolic volume 10.5% 17.0%
Central venous saturation (SvO2) 10.0% 34.5%
ASA, American society of anesthesiology respondents; ESA, European society
of anaesthesiology respondents.
Table 4 How do you routinely assess the hemodynamic
effects of volume expansion?
ASA
respondents
(n = 203)
ESA
respondents (n
= 162)
Answer options Response
percent
Response
percent
Increase in blood pressure 92.1% 75.3%
Increase in urine output 84.7% 73.5%
Decrease in heart rate 74.4% 75.3%
Increase in cardiac output 59.1% 54.3%
Decrease in pulse pressure variation
or systolic pressure variation
56.7% 54.9%
Decrease in plethysmographic
waveform variation
28.6% 25.9%
Increase in mixed venous saturation
(SvO2)
22.2% 18.5%
Decrease in stroke volume variation 21.7% 35.2%
Increase in central venous saturation
(SvO2)
19.2% 27.8%
ASA, American society of anesthesiology respondents; ESA, European society
of anaesthesiology respondents.
Table 5 In your opinion, what best predicts an increase
in cardiac output following volume expansion?
ASA
Respondents
(n = 190)
ESA
Respondents
(n = 158)
Answer options Response
percent
Response
percent
Transesophageal echocardiography 26.8% 17.7%
Cardiac output 21.1% 20.9%
Blood pressure 14.2% 5.7%
Pulse pressure variation or systolic
pressure variation
12.1% 12.0%
Mixed venous saturation (ScvO2) 7.9% 5.7%
Stroke volume variation 5.8% 21.5%
Clinical experience 5.3% 3.2%
Pulmonary capillary wedge pressure 2.1% 3.2%
Central venous saturation (SvO2) 2.1% 1.9%
Central venous pressure 1.1% 3.2%
Global end diastolic volume 1.1% 3.8%
Plethysmographic waveform variations 0.5% 1.3%
ASA, American society of anesthesiology respondents; ESA, European society
of anesthesiology respondents.
What is your first choice solution for volume 
expansion?
ASA Respondents ESA Respondents
Cristalloids HES Albumin
Dextrans Blood products Gelatins
Figure 5 What is your first choice solution for volume
expansion?
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Page 9 of 11implementation, and clinical practices in both Europe
and the US. In addition, clinical practice may be heavily
influenced by local factors that may not be justified by
basic physiological considerations and the recently pub-
lished body of evidence.
We postulate that we may be missing an enormous
opportunity for better hemodynamic understanding,
management and standardization. Clinicians may have
adequate physiological knowledge but clinical applica-
tion needs to be improved. Better communication,
exchange of ideas and exposure to new technologies
may decrease the observed differences between Ameri-
can and European anesthesiologists. On the local level,
practical bedside teaching, simulation, and well-defined
workshops may help to promote the use of appropriate
hemodynamic management and goal directed therapy
concepts. Recent and most important advances in
anesthesia and critical care have been provided by
“check list” implementations [32,33]. Standardization of
practice and making sure that adequate therapies are
delivered effectively may be the next step for hemody-
namic management of patients undergoing high-risk
surgery.
Key messages
￿ Our results point to a considerable gap between
the accumulating evidence about the benefits of
perioperative hemodynamic optimization and the
available technologies that may facilitate its clinical
implementation, and clinical practices in both Eur-
ope and the US.
￿ Clinical practice may be heavily influenced by local
factors that may not be justified by basic physiologi-
cal considerations and the recently published body
of evidence. We may thus be missing an enormous
opportunity for better hemodynamic understanding,
management and standardization.
￿ This lack of application of goal directed therapy
concepts is not related to a lack of knowledge.
￿ The results of this email survey with a low
response rate seems to emphasize the need for large
clinical studies in order to demonstrate the clinical
utility of intraoperative goal directed therapy during
high risk surgery.
Additional material
Additional file 1: Appendix 1. Full questionnaire sent to American
Society of Anesthesiologists members. A pdf. file with the full length
questionnaire.
Additional file 2: Appendix 1. Full questionnaire sent to the European
Society of Anaesthesiology members. A pdf. file with the full length
questionnaire.
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